Skip to main content
Fig. 1 | BMC Immunology

Fig. 1

From: Subcutaneous immunoglobulin replacement therapy in patients with immunodeficiencies – impact of drug packaging and administration method on patient reported outcomes

Fig. 1

Design of PFS. Figure was repurposed from Ayman R. Kafal, Donald C. Vinh & Mélanie J. Langelier [31] Prefilled syringes for immunoglobulin G (IgG) replacement therapy: clinical experience from other disease settings, Expert Opinion on Drug Delivery, 15:12, 1199-1209, https://doi.org/10.1080/17425247.2018.1546692 and is covered by the Creative Commons Attribution-NonCommercial-NoDerivatives License. PFS, pre-filled syringes

Back to article page